Abstract
Human immunodeficiency virus (HIV) has been implicated in neurological complications in developed countries. Developing countries have different viral clades and potentially different genetic and social risks for these complications. Baseline neurological performance measures associated with HIV infection have rarely been available from developing countries. The authors carried our a cross-sectional neurological evaluation of a cohort of community-dwelling treatment-naïve HIV-infected patients and similar control subjects from the same communities in Ethiopia. Blinded evaluation using standardized structured questionnaires and a neurological examination was performed by neurologists and treating physicians trained by an HIV neurology specialist. Quantitative performance measures for cognitive and motor function were employed. Data were analyzed with descriptive statistical methods, standard contingency table methods, and nonparametric methods. HIV-positive and control groups were similar by age, gender, and job site. Participants included 73 HIV-positive and 87 HIV-negative controls. Fingertapping speed in the dominant hand was more poorly performed in HIV positives than negatives (P = .01) and was significantly associated with HIV viral load levels (P = .03). Other quantitative neuropsychiatric tests including timed gait, grooved peg-board, task learning, and animal naming did not show significant differences between the two groups. The overall prevalence of central nervous system (CNS) and/or peripheral nervous system (PNS) disease did not significantly differ in the two populations. HIV patients had slowed fingertapping speed correlating with viral load. Other measures of CNS and/or peripheral nervous performance did not differ from controls. The unanticipated minor evidence of HIV-associated neurocognitive and peripheral nerve deficits in this untreated HIV-positive population invite further investigation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abebe A, Pollakis G, Fontanet AL, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Cornelissen M, Goudsmit J, Rinke de Wit TF (2000). Identification of a genetic subcluster of HIV type 1 subtype C (C’) widespread in Ethiopia. AIDS Res Human Retroviruses 16: 1909–1914.
Clifford DB, Jacoby RG, Miller JP, Seyfried WR, Glicksman M (1990). Neuropsychometric performance of asymptomatic HIV-infected subjects. AIDS 4: 767–774.
Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann Intern Med 107: 828–836.
Karnofsky DA, Abelman WH, Carver LF, et al (1948). The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1: 634–656.
Ministry of Health of the Federal Democratic Republic of Ethiopia (2000). AIDS in Ethiopia, pp 1–55.
Power C (2001). Retroviral diseases of the nervous system: pathogenic host response or viral gene-mediated neurovirulence? Trends Neurosci 24: 162–169.
Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, Chesebro B (1994). Demented and non-demented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 68: 4643–4649.
Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, Hagos M, Kliphuis A, Pollakis G, Krol A, Geskus R, Miedema F, Goudsmit J, Coutinho R, Fontanet AL (2002). Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Synd 30: 463–470.
Sacktor N, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Visscher B, Miller EN, Multicenter AIDS Cohort Study (MACS) (2003). Response to systemic HIV viral load suppression correlates with psychmotor speed performance. Neurology 61: 567–569.
Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005). The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19: 1367–1374.
Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL, the AZT Collaborative Working Group (1988). Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319: 1573–1578.
Tross S, Price RW, Navia BA, Thaler HT, Gold J, Hirsch DA, Sidtis JJ (1988). Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS 2: 81–88.
Tsegaye A, Rinke de Wit TF, Mekonnen Y, Beyene A, Aklilu M, Messele T, Abebe A, Coutinho R, Sanders E, Fontanet AL (2002). Decline in prevalence of HIV-1 infection and syphilis among young women attending antenatal care clinics in Addis Ababa, Ethiopia: results from sentinel surveillance, 1995–2001. J Acquir Immune Defic Synd 30: 359–362.
Woldemichael T, Fontanet AL, Sahlu T, Gilis H, Messele T, Rinke de Wit TF, Yeneneh H, Coutinho RA, Van Gool T(1998). Evaluation of the Eiken latex agglutination test for anti-Toxoplasma antibodies and seroprevalence of Toxoplasma infection among factory workers in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg 92: 401–403.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Neurologic AIDS Research Consortium funded by NINDS (NIH) NS032228.
Rights and permissions
About this article
Cite this article
Clifford, D.B., Mitike, M.T., Mekonnen, Y. et al. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. Journal of NeuroVirology 13, 67–72 (2007). https://doi.org/10.1080/13550280601169837
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280601169837